Global and USA Poliovirus Vaccine Inactivated Market Insights, Forecast to 2027

Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.

Market Analysis and Insights: Global and USA Poliovirus Vaccine Inactivated Market
This report focuses on global and USA Poliovirus Vaccine Inactivated market.
In 2020, the global Poliovirus Vaccine Inactivated market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In USA the Poliovirus Vaccine Inactivated market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Poliovirus Vaccine Inactivated Scope and Market Size
Poliovirus Vaccine Inactivated market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Poliovirus Vaccine Inactivated market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For USA market, this report focuses on the Poliovirus Vaccine Inactivated market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in USA.

Segment by Type
Human Diploid Cell
Monkey Kidney Cell

Segment by Application
Public
Private

By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA